CRON
Cronos Group IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$1.02B
P/E Ratio
0.00
EPS
$0.00
Beta
1.23
52W High
$3.43
52W Low
$1.84
50-Day MA
$2.61
200-Day MA
$2.60
Dividend Yield
—
Profit Margin
-1.14%
Forward P/E
26.18
PEG Ratio
—
About Cronos Group Inc
Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | $159.53M |
| Gross Profit (TTM) | $63.82M |
| EBITDA | -298,000 |
| Operating Margin | -2.98% |
| Return on Equity | 0.45% |
| Return on Assets | -0.80% |
| Revenue/Share (TTM) | $0.42 |
| Book Value | $2.85 |
| Price-to-Book | 0.95 |
| Price-to-Sales (TTM) | 6.98 |
| EV/Revenue | 1.279 |
| EV/EBITDA | 1.90 |
| Quarterly Earnings Growth (YoY) | 128.60% |
| Quarterly Revenue Growth (YoY) | 40.10% |
| Shares Outstanding | $373.66M |
| Float | $193.56M |
| % Insiders | 48.19% |
| % Institutions | 15.62% |
Historical Volatility
HV 10-Day
49.48%
HV 20-Day
40.41%
HV 30-Day
45.20%
HV 60-Day
39.47%
HV Rank
63.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($2.48 target)
3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026